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re s tr ic t io n  (IU G R ). F o lia  b io l. (K rak ó w ) 5 8 : 79-83 .
D is tu rb ed  tro p h o b la s t tu rn o v e r , a  k ey  p ro c e ss  in p la c en ta l p h y s io lo g y , m ay lead  to  a  nu m b er 
o f  p re g n a n c y -a sso c ia te d  p a th o lo g ie s . T h is  s tu d y  e x am in e s  PC N A  e x p re ss io n  and  d e sc rib e s  
an d  q u a n tif ie s  m o rp h o lo g ica l c h an g es  d u rin g  tro p h o b la s t tu rn o v e r  in p re te rm  p la c en ta s  and  
te rm  p la c en ta s  c o m p lic a te d  by  IU G R . T h e  n u m b er o f  C T F  c e lls  in c re a se d  tw o -fo ld  in p re te rm  
an d  IU G R  p la c en ta s . Л  c o n cu rre n t an d  s lig h tly  re d u c e d  p ro li fe ra tio n  ra te  o f  th e se  c e lls  w as 
a lso  fo u n d . T h e  n u m b er o f  ST F  nuc le i o f  te rm in a l v illi w as  lo w e r  by 21 %  in 1 U G R a n d  by 18% 
in p re te rm  p la c en ta s  (P > 0 .0 5 ). Л  s ta t is tic a lly  s ig n if ic a n t re d u c tio n  o f  th e  n u m b er o f  sy n cy tia l 
k n o ts  by  50%  as c o m p a red  to  th e  c o n tro l p la c en ta s  w as  o b se rv e d . C o rre la tio n s  b e tw een  
P C N A -re a c tiv e  C T F  nu c le i and  sy n cy tia l k n o ts . P C N A -re a c tiv e  C T F  nuc le i an d  C C O  
ac tiv ity , an d  C C O  ac tiv ity  an d  sy n c y tia l k n o ts  w e re  fo u n d . M o re o v e r , a  s tro n g  in v erse  
re la tio n  w as o b se rv ed  b e tw een  sy n cy tia l k n o ts  and  C T F  c e l ls ,  and  C C O  a c tiv ity  an d  C T F 
cells.
K ey w ords: IU G R  p la c en ta , p re te rm  p la c e n ta , tro p h o b la s t tu rn o v e r ,  p ro life ra tio n , 
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Trophoblast is a cell type specific to the pla­
centa. It covers the surface of placental villi sepa­
rating maternal and fetal blood circulations. The 
trophoblast consists of an inner layer of prolifer­
ated stem cells called the cytotrophoblast (CTF) 
and an outer multinucleated layer called the syn- 
cytiotrophoblast (STF). The STF layer is in perma­
nent contact with maternal blood. It plays an 
important role in placental functions such as gas 
exchange and active transport of substances 
needed for proper fetus development. Moreover, it 
also displays endocrine functions. Due to its high 
degree of differentiation, the syncytiotrophoblast 
does not display proliferation abilities (BOYD & 
HAMILTON 1970; BENIRSCHKE etal. 2006). Thus, 
the growth and regeneration of the STF during 
pregnancy depends on the continuous incorpora­
tion of villous CTF by fusion into STF. Due to this 
process, new proteins and mRNA are delivered to 
the syncytium. Old material is accumulated in 
structures called syncytial knots. Then, this mate­
rial is removed to the maternal blood circulation to 
equilibrate the constant influx of new material
through syncytial fusion into STF (HUPPERTZ etal. 
2002). Transformation of the trophoblast is strictly 
correlated with apoptosis. The early stages of 
apoptosis are correlated with differentiation of CTF 
and then with its fusion into STF (BLACK et al. 
2004). An incorporation of CTF by fusion into 
STF seems to delay subsequent steps of apoptosis. 
This results in the removal of total apoptotic nuclei 
within syncytial knots (Hu p p e r t z  et al. 1998; 
MAYHEW et al. 1999). Any aberrations in the 
function of these processes can result in various 
pregnancy complications, for example preeclamp­
sia (JOHANSEN et al. 1999; HUPPERTZ 2006). 
Higher proliferation rate and intensification of 
apoptosis in the villous trophoblast have been ob­
served in placentas with preeclampsia (ALLAIRE 
et al. 2000; ISHIHARA et al. 2002). Moreover, in­
tensification of apoptotic processes was found in 
the placental trophoblast complicated by intrauter­
ine fetus growth restriction (IUGR), (Er e l  et al. 
2001; ISHIHARA et al. 2002; LEVY et al. 2002).
The main goal of this work was the analysis of 
processes of transformation of the villous tropho-
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blast in human placenta derived from prematurely 
terminated (PT) and full-term pregnancies compli­
cated by IUGR. Both the IUGR and prematurely 
terminated pregnancies are important clinical 
problems of modern perinatology. Both clinical 
problems are associated with low birth weight, an 
increase of disease incidence and high perinatal 
mortality of newborns (KUFEL et al. 2003; 
Re d l i n e  2008). The cause of these pregnancy pa­
thologies is still unknown. However, it is already 
acknowledged that the placenta plays a crucial role 
in these pathologies (BRODSKY & CHRISTOU 
2004; Re d l i n e  2008).
Material and Methods
Collection of samples
Human placentas were obtained from mothers 
immediately after spontaneous delivery. Placentas 
were taken from 6 preterm pregnancies between 
34-37 weeks (preterm), 6 from term pregnancies 
(38-41weeks) complicated by IUGR, and 8 from 
normal term pregnancies (38-40 weeks). The lat­
ter placentas served as control material. IUGR 
cases were identified by deficient fetal growth on 
ultrasound scans and the final determinant was an 
individualized birth weight ratio below the 10th 
percentile. None of the women had smoking or 
drinking habits. No significant differences were 
observed in maternal age. Newborn birth weights 
and placental weights were measured (Fig. 1). Tis­
sue sections obtained from each placenta were 
studied by morphological and immunohisto- 
chemical methods.
Histological procedure
The placental tissues obtained were immediately 
fixed in a neutral phosphate-buffered 4% formal­
dehyde solution, dehydrated in a graded series of 
ethanol and embedded in paraffin. Serial sections 
of 6 m were deparaffinized and rehydrated through 
graded alcohol by standard histological proce­
dures. Then the tissue sections were processed for 
morphological analysis and immunohistochemi- 
cal detection of PCNA (proliferating cell nuclear 
antigen). PCNA functions as a co-factor for DNA 
polymerase delta in S phase and also during DNA 
synthesis associated with DNA damage repair 
mechanisms (KURKI et al. 1988). The temporal 
pattern of PCNA expression makes it a useful tool 
for the study of cell proliferation.
To quantify morphometric analyses of CTF and 
STF nuclei and the number of syncytial knots, tis­
sue sections were stained with (PAS) and Mayer’s 
hematoxilin. The number of nuclei within CTF 
and STF of terminal villi was counted under 250 x 
magnification and was referred to a 0.01 m m  vil­
lous cross section area. A quantification of syn­
cytial knots was conducted under the same 
microscopic conditions. Only terminal villi (cali­
ber about 60 ^m and half of the stromal cross sec­
tion occupied by capillary lumen) were taken into 
account. The outcomes express the average 
number of syncytial knots to villous cross section.
Immunohistochemistry
Deparaffinized and rehydrated sections of 6 /лm 
were immersed sequentially in 1 % FECb in metha­
nol for 30 min, blocked with normal serum and in­
cubated at 4°C overnight with monoclonal mouse 
anti-PCNA, clone PC 10 (Novocastra, UK) diluted 
1:100 in phosphate-buffered saline (PBS). PBS 
was used for all subsequent washes and for antise­
rum dilution. The next day, after several washes, 
the slides were incubated with a biotinylated sec­
ondary antibody (LAB-SA Detection System, 
ZYMED,US) for 10 min at room temperature, and 
streptavidin-peroxidase complex (LAB-SA De­
tection System, ZYMED, US) for 10 min at room 
temperature. The binding of primary antibody was 
visualized using diaminobenzidine (DAB) for 3-5 
min. After washing with distilled water, sections 
were counterstained with PAS, dehydrated in etha­
nol and xylene and mounted in the DPX medium 
(Fluka). Control reactions omitting the primary 
antibodies were always negative. The mean 
number of PCNA-immunoreactivity CTF nuclei 
were calculated in 0,01 mm" of the terminal villi 
cross sections area.
Morphometric calculations including numbers 
of CTF cells, STF nuclei and PCNA-positive nu­
Fig. 1. Mean placental weight (g) and newborn birth weight 
(g) ± SEM in the control, ÏUGR and preterm groups. 
*P<0.05 compared with control group.
clei were done with a microcomputer microscope 
image analyzer combined with the programme 
Cell-D.
Statistical methods
Means and standard errors of means (SEM) were 
calculated for each group. Comparisons between 
groups were carried out using Kruskal-Wallis 
ANOVAs and post hoc by Dunn’s multiple com­
parison tests. For all normally distributed vari­
ables, Pearson’s correlation coefficients were 
calculated. Statistical significance was established 
at P<0.05.
Results and Discussion
In the present study we found a two-fold increase 
of the number of CTF cells in preterm and IUGR 
placentas (Fig. 2) and a slightly reduced prolifera­
tion rate of these cells (Fig. 3); a statistically sig-
Fig. 2. Mean number and ± SEM o f CTF cells and STF nuclei (per 0.01 mm" o f tenninal villi cross section area) and syncytial 
knots (per tenninal villi cross section) in the control, IUGR andpretenn placental trophoblast. *P<0.01 compared with control 
group.
Fig. 3. Immunohistochemical staining o f PCNA to identify proliferating CTF cells (arrows) in the control (A), IUGR (В) ant) 
Pretenn (C) placental tenninal villi. D. Results are expressed as the mean ±SEM number o f PCNA-positive nuclei/0.01 mm" 
tenninal villi cross section area. P>0.05.
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nificant reduction of the number of syncytial knots 
by 50% as compared to the control placentas (Fig. 2) 
and slightly reduced but insignificant number of 
STF nuclei of terminal villi. We also observed a 
decrease of the mean birth weight of the newborns 
from preterm and IUGR pregnancies which corre­
lated with the mean weight of the placentas (Fig. 1).
Proper growth and functionality of the human 
placenta during pregnancy plays the most impor­
tant role in the development of the fetus. Numer­
ous studies have revealed placental dysfunctions 
as the main cause of various pregnancy complica­
tions (Br o d s k y  & Ch r i s t o u  2004; f o x  1997; 
MEHTA et al. 2006). A low birth weight of new­
borns is one ofthe symptoms ofpregnancies termi­
nated before the delivery term and complicated 
withIUGR(ZA W etal. 2003; KAM ATHetal. 2006). 
In this study, the mean birth weights of newborns 
from preterm and IUGR pregnancies were lower 
compared to the control newborns (Fig. 1) and cor­
related with the mean placenta weight (r=0.8085, 
P<0.001). This study not only confirms the rela­
tionship observed by many researches (JACKSON  
et al. 1995; DAAYANA et al. 2004) but also under­
lines the role of the placenta in these pathologies.
The villous trophoblast plays a main role in the 
functionality of the placenta. It is subject to the 
continuous transformation, differentiation and fu­
sion of CTF into STF cells. The first stages of tro- 
phoblast transformation include proliferation of 
CTF cells followed by their differentiation. This 
process results in the fusion of CFT cells into the 
syncytiotrophoblast. In initially distinct and con­
tinuous cytotrophoblast layers, the number of cells 
gradually decreases in normal pregnancy, so that 
only a small number of CTF cells remains in the 
placenta of a full-term pregnancy (BENIRSCHKE et 
al. 2006; FOX 1997). However, the two-fold in­
crease of CTF cells in terminal villi from preterm 
and IUGR placentas was observed in the analyzed 
material as compared to control group (P<0.01; 
Fig. 2). A concurrent and slightly reduced prolif­
eration rate of these cells was also found (P>0.05; 
Fig. 3). Taking into consideration the decrease in 
the number of proliferated CTF cells during preg­
nancy (ISHIHARA et al. 2000), it should be ex­
pected that most of these cells are in preterm 
placentas. However, in the analyzed preterm pla­
centas of CTF nuclei with PCNA reactivity, the 
number of cells was lower by 13% as compared to 
control placentas (Fig. 3). This observation can 
provide information about cell proliferation disor­
ders in these placentas. Reduced proliferation ac­
tivity of CTF cells in placentas complicated by 
IUGR was also detected by MACAR et al. (1995), 
Ch e n etal. (2002), andGU RELetal. (2003),using 
different cell proliferation markers. However, in­
creased cell proliferation was observed in preeclamp­
sia placentas (LEUNG et al. 2001).
The reduced proliferation rate and accumulation 
of CTF cells in the trophoblast of placental termi­
nal villi of preterm and IUGR indicates the reduc­
tion of supplying processes of the syncytiotropho- 
blast layer in new cellular material. This can result 
in improper growth and functionality of the layer and 
acceleration of syncytial apoptosis (HUPPERTZ et al. 
1999), contributing to placental transport mal­
function. The analysis of STF nuclei and syncytial 
knots also confirms this phenomenon. The average 
number of STF nuclei per cross-section (0.01 mm") 
of terminal villi was lower by ~ 21 % in IUGR pla­
centas and 18% in preterm placentas. However, 
these data were not statistically significant (Fig. 2). 
However, a statistically significant reduction of 
the number of syncytial knots by 50% as compared 
to the control placentas was observed. This reduc­
tion runs parallel with lower numbers of STF nu­
clei in preterm and IUGR placentas. On average, 
one terminal villous of control placental cross­
section corresponds to 0.76 syncytial knots. This 
ratio was 0.42 and 0.38 for IUGR and preterm pla­
centas, respectively (P<0.01; Fig. 2). The correla­
tion between the number of syncytial knots and the 
CTF cells (r = - 0.7327, P = 0.001) and between the 
number of CTF nuclei with PCNA-reactivity and 
syncytial knots (r = 0.4929, P = 0.04) shows the re­
lationship between the proper course of the early 
stages in transformation of villous trophoblast and 
the terminal phase of this process.
Because fusion and further syncytial apoptosis is 
an energy-dependant process, HUPPERTZ et al. 
(2006) stated that under moderate hypoxia condi­
tions and during disturbed transport of protein and 
mRNA to the STF, no stages of apoptosis or re­
moval of apoptotic nuclei within the syncytial 
knots occur. As a consequence of this process, the 
old and partially apoptotic syncytial nuclei are re­
moved by necrosis or aponecrosis (FORMIGLI et 
al. 2000). This phenomenon results in local tissue 
damage (HUPPERTZ & KINGDOM 2004). Many 
studies (He a z e l l  et al. 2008; BENIRSCHKE et al. 
2006) draw attention to the influence of hypoxia 
on the inhibition of CTF cell differentiation and 
aggregation. The activity of the main oxidative en­
zyme, cytochrome c oxidase (CCO), was histo- 
chemically examined in the analyzed group of 
placentas (described in a previous paper; 
ZADROŻNA et al. 2009). The activity of the CCO 
was lower by 11% and 28% in IUGR and preterm 
placentas, respectively, as compared to control 
placentas. Moreover, the CCO activity was sig­
nificantly correlated with the number of CTF cells 
(r = -0.5938, P = 0.001), PCNA-reactive CTF nu­
clei (r = 0.4931, P = 0.04), and syncytial knots (r = 
0.5799, P = 0.001).
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In conclusion, a different model of transforma­
tion of placental villous trophoblast in IUGR and 
preterm was described based on the obtained re­
sults. This model undoubtedly could play a role in 
the IUGR pathomechanism and premature birth. 
The observed changes were more intense in pre­
term placentas, which may result in pregnancy 
ending before term.
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